Skip to main content

Advertisement

Log in

Prevalence of potentially inappropriate medications in older adults in Argentina using Beers criteria and the IFAsPIAM List

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Medications in which the risk of adverse events exceeds the expectations of clinical benefits are called potentially inappropriate medications (PIMs). To identify the use of PIMs in elderly patients, the most commonly used tool are the Beers criteria, developed for the population of the United States. Recently, a consensus panel of Argentine experts developed the first Latin American tool, called the IFAsPIAM List. Objective The present study aimed to identify PIM prescriptions in elderly outpatients, to estimate the prevalence of PIMs, and to evaluate their possible relation with polypharmacy and gender and age of the patients. Also, we aimed to compare the results obtained by using the Beers criteria and the IFAsPIAM List. Setting Ten community pharmacies of Rosario, Santa Fe, Argentina. Methods A cross-sectional observational study was conducted between February and September 2015. Data were acquired from 56,952 prescriptions prescribed to 2231 patients aged 65 years old or older. To detect the use of PIMs, we used two tools: the Beers criteria and the IFAsPIAM List. Main outcome measure The prevalence of PIM use according to the Beers criteria and the IFAsPIAM List. Results The monthly average of medications dispensed per patient was 4.35 ± 2.18 and 42.27% of the patients presented major polypharmacy. The prevalence of PIMs was 72.75% according to the Beers criteria and 71.13% according to the IFAsPIAM List (Kappa coefficient k = 0.72), and was significantly higher in patients with major polypharmacy, older than 75 years old, and females. The most frequent PIMs prescribed were anxiolytics, analgesics and antipsychotics. Conclusions The IFAsPIAM List is an effective tool to evaluate the prescription of PIMs in the elderly. The results showed a high prevalence of PIMs with a multicausal origin and directly associated with polypharmacy. As clarified by the authors of the IFAsPIAM List, the criteria specified in the list do not substitute the clinical evaluation of each patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Pandraud-Riguet I, Bonnet-Zamponi D, Bourcier E, Buyse M, Laribe-Caget S, Frémont P, et al. Monitoring of potentially inappropriate prescriptions in older inpatients: a French multicenter study. J Am Geriatr Soc. 2017;65(12):2713–9.

    Article  PubMed  Google Scholar 

  2. IDELAS-UCES. La población argentina aumentó su edad promedio respecto de la media del mundo. In: Boletín Mensual IDELAS. http://la5pata.com/2017/02/09/idelas-uces-la-poblacion-argentina-aumento-su-edad-promedio/. Accessed 1 Dec 2018.

  3. World Health Organization. A glossary of terms for community health care and services for older persons. WHO Centre for Health Development; 2004.

  4. Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997;53(1):7–11.

    Article  CAS  PubMed  Google Scholar 

  5. Chiapella LC, Montemarani Menna J, Mamprin ME. Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation. Int J Clin Pharm. 2018. https://doi.org/10.1007/s11096-018-0663-3.

    Article  PubMed  Google Scholar 

  6. Fick DM, Mion LC, Beers MH, Waller JL. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 2008;31(1):42–51.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007;63(2):177–86.

    Article  PubMed  Google Scholar 

  8. Campanelli CM. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.

    Article  PubMed Central  Google Scholar 

  9. Steinman MA, Beizer JL, DuBeau CE, Laird RD, Lundebjerg NE, Mulhausen P. How to use the American Geriatrics Society 2015 Beers Criteria—a guide for patients, clinicians, health systems, and payors. J Am Geriatr Soc. 2015;63(12):e1–7.

    Article  PubMed  Google Scholar 

  10. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arzteblatt Int. 2010;107(31–32):543–51.

    Google Scholar 

  11. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.

    Article  PubMed  Google Scholar 

  12. Renom-Guiteras A, Meyer G, Thürmann PA. The EU (7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861–75.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Oliveira M, Amorim W, Oliveira C, Coqueiro H, Gusmão L, Passos L. Consenso brasileiro de medicamentos potencialmente inapropriados para idosos. Geriatr Gerontol Aging. 2016;10(4):168–81.

    Article  Google Scholar 

  14. Marzi MM, Pires MS, Quaglia NB. Ingredientes Farmaceuticos Activos Potencialmente Inapropiados en Adultos Mayores: Lista IFAsPIAM: Panel de Consenso Argentino. Value Health Reg Issues. 2018;17:38–55.

    Article  PubMed  Google Scholar 

  15. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2016. 19 ed. Oslo, Norway: 2015.

  16. Chiapella LC, Montemarani Menna J, Mamprin ME. Potentially inappropriate medications in elderly ambulatory patients: a comparative study between a primary health care center and a community pharmacy. Value Health Reg Issues. 2018;17:119–25.

    Article  PubMed  Google Scholar 

  17. Anmat. Vademecum Nacional de Medicamentos. http://anmatvademecum.servicios.pami.org.ar/. Accessed 1 Dec 2018.

  18. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.

    Article  Google Scholar 

  19. Holmes HM, Luo R, Kuo YF, Baillargeon J, Goodwin JS. Association of potentially inappropriate medication use with patient and prescriber characteristics in Medicare Part D. Pharmacoepidemiol Drug Saf. 2013;22(7):728–34.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lopes LM, Figueiredo TP, Costa SC, Reis AM. Use of potentially inappropriate medications by the elderly at home. Ciencia saude coletiva. 2016;21(11):3429–38.

    Article  PubMed  Google Scholar 

  21. Cano JP, García AA, Cánovas JJG, Ruiz JFS, Rausell VJR, Soto MT. Prescripción potencialmente inadecuada en mayores de 65 años según los criterios de Beers originales y su versión adaptada. Atención Primaria. 2018;50(2):106–13.

    Article  Google Scholar 

  22. Fajreldines A, Insua J, Schnitzler E. Prevalencia de prescripcion potencialmente inapropiada de medicamentos en adultos mayores. Revista de calidad asistencial: organo de la Sociedad Espanola de Calidad Asistencial. 2016;31(5):279–84.

    Article  CAS  Google Scholar 

  23. Chang CM, Liu PYY, Yang YHK, Yang YC, Wu CF, Lu FH. Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy. 2005;25(6):831–8.

    Article  PubMed  Google Scholar 

  24. Bertoldo P, Beltramo A, Rimoldi E, Bertoldo J, Vidaurre M, Valenciaga M, et al. Patrones de prescripción de benzodiacepinas, antidepresivos e hipnóticos en diferentes ciudades de Argentina. Rev AAFH. 2018;5(1):4–15.

    Google Scholar 

  25. Díaz-Gutiérrez MJ, Martinez-Cengotitabengoa M, de Adana ES, Cano AI, Martínez-Cengotitabengoa MT, Besga A, et al. Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas. 2017;101:17–22.

    Article  CAS  PubMed  Google Scholar 

  26. Thaler HW, Sterke C, Van Der Cammen TJ. Association of proton pump inhibitor use with recurrent falls and risk of fractures in older women: a study of medication use in older fallers. J Nutr Health Aging. 2016;20(1):77–81.

    Article  CAS  PubMed  Google Scholar 

  27. World Health Organization. WHO’s pain ladder. 2011. http://www.who.int/cancer/palliative/painladder/en. Accessed 2 Dec 2018.

  28. Campbell S, Cantrill J. Consensus methods in prescribing research. J Clin Pharm Ther. 2001;26(1):5–14.

    Article  CAS  PubMed  Google Scholar 

  29. Weyer G, Babej-Dölle R, Hadler D, Hofmann S, Herrmann W. A controlled study of 2 doses of idebenone in the treatment of Alzheimer’s disease. Neuropsychobiology. 1997;36(2):73–82.

    Article  CAS  PubMed  Google Scholar 

  30. Mariotti C, Solari A, Torta D, Marano L, Fiorentini C, Di Donato S. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology. 2003;60(10):1676–9.

    Article  CAS  PubMed  Google Scholar 

  31. Gómez V, Armesto J, Calvo M, Candás M, Fidalgo S, Rigeira A. Utilidad terapéutica de los medicamentos financiados por el Sistema Nacional de Salud. Madrid: INSALUD; 2001.

    Google Scholar 

  32. Makari J, Cameron K, Battistella M. Domperidone-associated sudden cardiac death in the general population and implications for use in patients undergoing hemodialysis: a literature review. Can J Hosp Pharm. 2014;67(6):441.

    PubMed  PubMed Central  Google Scholar 

  33. Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, et al. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria. Eur J Clin Pharmacol. 2016;72(5):583–91.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Chang CB, Yang SY, Lai HY, Wu RS, Liu HC, Hsu HY, et al. Application of three different sets of explicit criteria for assessing inappropriate prescribing in older patients: a nationwide prevalence study of ambulatory care visits in Taiwan. BMJ Open. 2015;5(11):e008214.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123–32.

    Article  PubMed  Google Scholar 

  36. Cojutti P, Arnoldo L, Cattani G, Brusaferro S, Pea F. Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs? Pharmacoepidemiol Drug Saf. 2016;25(9):1070–8.

    Article  CAS  PubMed  Google Scholar 

  37. Chui MA, Stone JA, Holden RJ. Improving over-the-counter medication safety for older adults: a study protocol for a demonstration and dissemination study. Res Soc Adm Pharm. 2017;13(5):930–7.

    Article  Google Scholar 

  38. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by Universidad Nacional de Rosario (No. 445/2015) and a grant from Secretaría de Estado de Ciencia, Tecnología e Innovación-SECTEI-(No. 2010-174-14), Santa Fe, Argentina.

Conflicts of interest

The authors report no conflict of interest in the conduction of this study or the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to María Eugenia Mamprin.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiapella, L.C., Montemarani Menna, J., Marzi, M. et al. Prevalence of potentially inappropriate medications in older adults in Argentina using Beers criteria and the IFAsPIAM List. Int J Clin Pharm 41, 913–919 (2019). https://doi.org/10.1007/s11096-019-00858-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-019-00858-8

Keywords

Navigation